Timothy P. Lynch’s Stonepine Capital Portfolio: Top 5 Healthcare Stocks

Page 1 of 5

In this article, we discuss the top 5 healthcare stock picks of Timothy P. Lynch’s Stonepine Capital. If you want our detailed analysis of these stocks, go directly to Timothy P. Lynch’s Stonepine Capital Portfolio: Top 10 Healthcare Stocks.

5. Ovid Therapeutics Inc. (NASDAQ:OVID)

Stonepine Capital’s Stake Value: $10,930,000

Percentage of Stonepine Capital’s 13F Portfolio: 4.97%

Number of Hedge Fund Holders: 15

Ovid Therapeutics Inc. (NASDAQ:OVID) is a biopharmaceutical company with several unique medicines in its pipeline, meant for the treatment of rare neurological disorders. As of the third quarter, Lynch’s Stonepine Capital owns 3.25 million shares in Ovid Therapeutics Inc. (NASDAQ:OVID), worth $10.93 million, representing 4.97% of the firm’s total investments. 

Ovid Therapeutics Inc. (NASDAQ:OVID) posted its Q3 results on November 10, with EPS for the quarter totaling -$0.17, beating estimates by $0.01. 

Mark Lampert’s Biotechnology Value Fund / BVF Inc is the leading shareholder of Ovid Therapeutics Inc. (NASDAQ:OVID), with 6.63 million shares worth $22.28 million. Overall, 15 hedge funds in the Q3 database of Insider Monkey reported owning stakes in Ovid Therapeutics Inc. (NASDAQ:OVID), valued at $65 million. 

Page 1 of 5